by fisherdev@fisherdigital.com.au | May 12, 2025 | Uncategorized
This week’s expert, Hepatologist and Key Opinion Leader Scott Friedman, joins Roger to advances in acceptance of gene therapy and knowledge in other areas of basic liver science. When discussing science, he pays particular attention to findings on the diversity of...
by fisherdev@fisherdigital.com.au | May 12, 2025 | Uncategorized
This weekend’s Newsmaker, Indiana University hepatologist and key opinion leader Naga Chalasani, joins Roger Green to discuss Early Experience with Resmetirom To Treat Metabolic-Associated Steatohepatitis with Fibrosis in a Real-World Setting, an article his group...
by fisherdev@fisherdigital.com.au | May 12, 2025 | Uncategorized
This conversation is the opening segment of SurfingMASH’s April discussion of drug development in memory of Stephen A. Harrison. In addition to co-hosts Jörn Schattenberg, Louise Campbell and Roger Green, panelists include hepatologists and key opinion leaders Sven...
by fisherdev@fisherdigital.com.au | May 12, 2025 | Uncategorized
00:00:00 – Surf’s Up: Season 6 Episode 5 Host Roger Green briefly describes this episode’s three sections and introduces Roundtable guests. The Roundtable panel shares groundbreakers. 00:00:00 – Surf’s Up: Season 6 Episode 5 00:10:39 – Roundtable: A Deep Dive Into...
by fisherdev@fisherdigital.com.au | May 12, 2025 | Uncategorized
This week’s Newsmaker is Mike Betel, Founder of the Fatty Liver Alliance. He discusses some of the reasons that key MASLD Patient Advocates like himself are getting more visibility at a broader swath of global conferences and the messages he delivers at the...
